Author Archives: Scalper1

Sarepta Upgraded On Promising Muscular-Dystrophy Drug

Biotech Sarepta Therapeutics (SRPT) got an upgrade and a price target increase Wednesday, a day after it said the FDA had finally accepted its filing for muscular-dystrophy drug eteplirsen. Late Tuesday, Sarepta said the agency had granted eteplirsen priority review and set its deadline for making an approval decision at Feb. 26. The drug treats cases of Duchenne muscular dystrophy (DMD) associated with a genetic mutation of exon 51, which

The ETF Monkey Vanguard Core Portfolio: Weathering The Storm And A Rebalance

Summary Since the inception of the model portfolio on 6/30/15, the markets have endured a turbulent period, with all 3 major U.S. averages in correction territory. The situation with foreign stocks, particularly those of emerging markets, has been even worse. In this article, we will evaluate both how the portfolio has held up and what lessons can be learned. I will also rebalance the portfolio for the first time, both explaining the rationale and assessing the cost of doing so. Back on July 1, I wrote an article presenting the ETF Monkey Vanguard Core Portfolio . Readers unfamiliar with the article may wish to review it before proceeding further. However, I will offer a quick summary here. That article linked to three previous articles I had written featuring suggested “core” Vanguard ETFs for Domestic Stocks, Bonds, and Foreign Stocks, as follows: Vanguard Total Stock Market ETF (NYSEARCA: VTI ) Vanguard FTSE All-World ex-U.S. ETF (NYSEARCA: VEU ) Vanguard Total Bond Market ETF (NYSEARCA: BND ) I next reviewed various Vanguard target-date funds to offer suggested weightings for various age groups, based on professionally-designed portfolios. Finally, I selected one of those age groups and built a theoretical $50,000 portfolio, developing it via an Excel spreadsheet and tracking it on Google Finance. The model portfolio was “purchased” as of the closing price of the three ETFs on June 30, 2015. As a reference point to evaluate the overall performance of the portfolio, the S&P 500 index closed that day at 2,063.11. I had not planned to write a follow-up article until the end of the 3rd quarter, using 9/30/15 as my point of comparison. That, however, was before the extreme turmoil that hit the markets during August. Emerging markets, led by China, dropped precipitously. In turn, this led to a sharp drop in U.S. markets culminating on 8/24/15, with a 1,000+ point drop in the Dow at the open and the day ending with all 3 major U.S. averages in correction territory. The S&P 500 closed the day at 1,893.21, 8.24% lower than the reference point for my model portfolio. Evaluating the ETF Monkey Vanguard Core Portfolio So how did the portfolio perform over that period? Here’s a picture of the Google Finance page for the portfolio as of the close on 8/24/15. Have a look, and then I will offer a few comments. (click to enlarge) First, the portfolio received two dividends totaling $34.88 from BND between 6/30 and 8/24, raising our original cash balance of $24.65 after all purchases to the current $59.53. Overall the portfolio decreased by 7.79%, a decrease of .45% less than the S&P 500 index. Let’s break that down. Domestic Stocks – VTI, which comprised 55.67% of our starting portfolio, decreased by 8.34%, roughly equal with the S&P 500. Remembering that we incurred a $7.95 commission to purchase the ETF, this is basically market performance. Foreign Stocks – VEU, which comprised 27.20% of our starting portfolio, decreased by 12.08%. VEU is approximately 19% in emerging markets, including a 5.4% weighting in China. This ETF was hit especially hard by the extreme weakness in those markets since 6/30. Bonds – BND, which comprised 17.08% of our starting portfolio, actually increased by .84%, providing some much-needed stability. Including the dividends, we have actually earned a return of 1.25% to-date. This is notable given the supposedly bad timing to be in bonds, in view of the “inevitable” rise in interest rates. I might note that, because I strictly followed the Vanguard target-date weightings, the portfolio basically held no cash. At the time the portfolio was built, many commentators suggested holding at least a modest percentage in cash. Clearly, a cash cushion would have been helpful in the short term. Overall, however, I am satisfied with the results. During a particularly turbulent stretch in emerging markets–and with no cash cushion–the portfolio has done a little better than the S&P 500. Actively Rebalancing the Portfolio However, this leads nicely to our next topic, that of periodically rebalancing a portfolio to stay true to one’s investment goals. Here are the same values displayed in the Google Finance picture shown above, but moved into Excel to allow for a little analysis. (click to enlarge) Here is what I want you to notice: Our domestic stock allocation is still very close to our target. At 55.27%, it is a mere .23% off our target of 55.50%. In terms of dollars, it is only $106.73 away from the desired target when evaluated against our overall (though lower) portfolio balance. If you think about this intuitively, it makes sense. Although VTI has decreased in value by 8.34%, our overall portfolio has declined by 7.79%. As a result, our relative weighting in VTI has barely moved. VEU and BND, however, are another story. VEU has declined by a particularly brutal 12.08%, while BND has actually increased slightly in value. As a result, VEU is now underweight by 1.06% (25.94% vs. our target of 27.00%). In contrast, BND is overweight by 1.16% (18.66% vs. our target of 17.50%). Based on this, I executed two trades to rebalance our portfolio, as follows: I sold 5 shares of BND at $82.02, generating $402.15 in cash ($410.10 – $7.95 commission). I bought 10 shares of VEU at $42.77, spending $435.65 ($427.70 + $7.95 commission). Here’s how the portfolio looks now: (click to enlarge) You will notice that our cash balance has dropped by $33.50, the net of the two transactions. You will also notice that our overall portfolio value has dropped by $15.90, the total amount of the commissions to execute the two transactions. This is a graphic representation of the concept that, unless one can trade commission-free, all rebalancing transactions do take their toll on our total return. NOTE: In the “real world,” I probably would not have executed a rebalancing transaction for such a small dollar amount unless I could have done it commission-free. With a portfolio of this size, I likely would have waited until I was $1,000 – $1,500 out of balance before doing anything. However, I felt that this was a good time to do this as a learning exercise. Summary and Conclusion So there you have it, the first performance update and rebalancing of the ETF Monkey Vanguard Core Portfolio. Here are my three takeaways from this period: Overall, I was happy with the performance of the portfolio. During a period of severe market turmoil in both domestic and foreign stocks, particularly in the emerging markets, the portfolio held up reasonably well. There are benefits to being properly diversified in various asset classes, even those that are supposedly out of favor. In the case of BND, not only did it offer some stability during this turbulent period, it even provided funds to rebalance into a beaten down asset class, foreign stocks. That it is beneficial to actively rebalance the portfolio when one or more asset classes vary greatly from the desired weighting. However, one must be mindful of the costs involved and act accordingly. Happy investing! Disclosure: I am/we are long VTI, BND, VEU. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Additional disclosure: I am not a registered investment advisor or broker/dealer. Readers are advised that the material contained herein should be used solely for informational purposes, and to consult with their personal tax or financial advisors as to its applicability to their circumstances. Investing involves risk, including the loss of principal.

Best And Worst Q3’15: Mid Cap Growth ETFs, Mutual Funds And Key Holdings

Summary The Mid Cap Growth style ranks eighth in Q3’15. Based on an aggregation of ratings of 11 ETFs and 382 mutual funds. MDYG is our top-rated Mid Cap Growth ETF and IMIDX is our top-rated Mid Cap Growth mutual fund. The Mid Cap Growth style ranks eighth out of the 12 fund styles as detailed in our Q3’15 Style Ratings for ETFs and Mutual Funds report. It gets our Neutral rating, which is based on an aggregation of ratings of 11 ETFs and 382 mutual funds in the Mid Cap Growth style. See a recap of our Q2’15 Style Ratings here. Figures 1 and 2 show the five best and worst-rated ETFs and mutual funds in the style. Not all Mid Cap Growth style ETFs and mutual funds are created the same. The number of holdings varies widely (from 23 to 626). This variation creates drastically different investment implications and, therefore, ratings. Investors seeking exposure to the Mid Cap Growth style should buy one of the Attractive-or-better rated ETFs or mutual funds from Figures 1 and 2. Figure 1: ETFs with the Best & Worst Ratings – Top 5 (click to enlarge) * Best ETFs exclude ETFs with TNAs less than $100 million for inadequate liquidity. Sources: New Constructs, LLC and company filings Figure 2: Mutual Funds with the Best & Worst Ratings – Top 5 (click to enlarge) * Best mutual funds exclude funds with TNAs less than $100 million for inadequate liquidity. Sources: New Constructs, LLC and company filings The State Street SPDR S&P 400 Mid Cap Growth ETF (NYSEARCA: MDYG ) is the top-rated Mid Cap Growth ETF and the Professionally Managed Portfolios Congress Mid Cap Growth Fund (MUTF: IMIDX ) is the top-rated Mid Cap Growth mutual fund. Both earn an Attractive rating. The QuantShares U.S. Market Neutral Momentum Fund ETF (NYSEARCA: MOM ) is the worst-rated Mid Cap Growth ETF and the Starboard Investment Goodwood SMID Cap Discovery Fund (MUTF: GAMAX ) is the worst-rated Mid Cap Growth mutual fund. MOM earns a Neutral Rating and GAMAX earns a Very Dangerous rating. The Buckle, Inc. (NYSE: BKE ) is one of our favorite stocks held by Mid Cap Growth funds and earns our Very Attractive rating. Over the past decade, the company has grown after-tax profit (NOPAT) by 14% compounded annually. The company currently earns a top-quintile return on invested capital ( ROIC ) of 32%, which is more than double the 15% earned in 2005. Furthermore, Buckle has maintained a steady NOPAT margin of 15% for the past six years. Despite the fundamental strength of the business, its stock remains undervalued. At the current price of $40/share, Buckle has a price to economic book value ( PEBV ) ratio of 0.0. This ratio implies that the market expects Buckle’s profits to permanently decline by 20%. While the retail sector has its ups and downs, this low expectation ignores the profitability Buckle has maintained over its lifetime. If the company can grow NOPAT by just 6% compounded annually for the next ten years , the stock is worth $74/share – an 85% upside. ServiceNow (NYSE: NOW ) is one of our least favorite stocks held by Mid Cap Growth funds and earns our Dangerous rating. Much like other cloud companies we have covered, ServiceNow has never turned a profit since going public. NOPAT declined from -$30 million in 2012 to -$141 million in 2014. On top of falling profits, the company earns a bottom-quintile ROIC of -74%. Investors are ignoring these fundamental issues in favor of misleading revenue growth, and the stock remains overvalued as a result. To justify the current price of $69/share, ServiceNow must immediately achieve a positive pre-tax (NOPBT) margin of 10% (compared to -21% in 2014) and grow revenue by 31% compounded annually for the next 15 years . We feel the expectations embedded in NOW are far too optimistic. Figures 3 and 4 show the rating landscape of all Mid Cap Growth ETFs and mutual funds. Figure 3: Separating the Best ETFs From the Worst Funds (click to enlarge) Sources: New Constructs, LLC and company filings Figure 4: Separating the Best Mutual Funds From the Worst Funds (click to enlarge) Sources: New Constructs, LLC and company filings D isclosure: David Trainer and Max Lee receive no compensation to write about any specific stock, style, style or theme. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.